Clinical Trial Update: Study to Evaluate the Fecal Microbiota Transplantation (FMT) in the Treatment of Ulcerative Colitis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial in active ulcerative colitis is evaluating fecal microbiota transplantation (FMT) and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Active Ulcerative Colitis (UC) | Phase 1 | Status: RECRUITING